Skip to main content

Table 3 Differences between parameters that interact with FGF23 in the CKD stages

From: Deviations from the expected relationship between serum FGF23 and other markers in children with CKD: a cross-sectional study

n = 144

CKD Stage I

n = 59

CKD Stage II

n = 31

CKD Stage III

n = 29

CKD Stage IV

n = 14

CKD Stage V

n = 11

p

Cystatin C eGFR [mL/min/1.73 m2]

Median (IQR)

126.56

(101.85–159.61)

74.65

(69.43–79.08)

42.30

(36.76–53.67)

21.47

(17.87–26.58)

11.53

(10.69–13.76)

0.000*

FGF23 [pg/mL]

Median (IQR)

40.45

(31.66–50.00)

45.19

(34.51–55.32)

63.79

(41.27–162.94)

133.64

(75.05–539.91)

535.44

(158.45–1249.95)

0.000*

Delta FGF23 [pg/mL]

Median (IQR)

1.79

(−8.17 to 11.14)

−6.68

(−15.58 to 7.89)

−25.39

(−81.04 to 14.73)

−144.33

(−276.82 to 82.31)

17.17

(−437.13 to 682.81)

0.111

Phosphate [mmol/L]

Median (IQR)

1.26

(1.07–1.38)

1.25

(1.15–1.38)

1.26

(1.19–1.44)

1.62

(1.37–1.88)

2.18

(1.51–3.17)

0.000*

Ionized Calcium

[mmol/L]

Mean SD

1.15 ± 0.06

1.17 ± 0.10

1.16 ± 0.093

1.10 ± 0.070

1.02 ± 0.083

0.000*

1,25 (OH)2 Vit D [pmol/L]

Median (IQR)

89.00

(70.75–128.25)

79.00

(62.00–121.50)

60.00

(36.50–81.00)

45.50

(21.50–89.25)

11.00

(10.00–34.00)

0.000*

PTH [pmol/L]

Median (IQR)

3.90

(2.80–5.50)

5.10

(3.75–8.20)

9.15

(7.17–12.52)

17.50

(11.52–70.27)

43.65

(7.20–112.65)

0.000*

pH

Mean SD

7.36 ± 0.041

7.34 ± 0.033

7.34 ± 0.052

7.30 ± 0.080

7.39 ± 0.076

0.003*

Bicarbonate

[mmol/L]

Mean SD

26.39 ± 3.27

24.58 ± 3.24

24.30 ± 3.98

28.08 ± 7.47

30.30 ± 4.44

0.000*

CRP

Median (IQR)

1.00

(0.59–3.67)

0.59

(0.56–2.82)

1.55

(0.59–3.60)

0.59

(0.59–4.85)

3.55

(2.55–10.90)

0.010*

  1. *denotes significant associations (p < 0.05)
  2. One-way ANOVA and Kruskal-Wallis test. For a significant p < 0.05